報價延遲最少15分鐘:2025/01/21 08:47 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
-- 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.81/0.91
|
|
企業價值
1.23B
|
| 資產負債 |
|
每股賬面淨值
6.88
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
89.08M
|
|
每股收益
1.66
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 08:47 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The Company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment. |